Literature DB >> 2227926

Giant cell tumor of the pancreas of mixed osteoclastic and pleomorphic cell type: evidence for a histogenetic relationship and mesenchymal differentiation.

K B Lewandrowski1, L Weston, G R Dickersin, D W Rattner, C C Compton.   

Abstract

We describe a giant cell tumor of the pancreas composed of a mixture of osteoclastic and pleomorphic cell types. This rare tumor had a unique immunohistochemical profile. Both types of tumor giant cells stained for vimentin, alpha-1-antitrypsin, alpha-1-antichymotrypsin, synaptophysin, muscle actin, and neuron-specific enolase, but not for epithelial markers. Electron microscopy showed cells which resembled primitive fibroblasts and osteoclast with no epithelial features. These findings are most consistent with mesenchymal differentiation. The extensive homologies in immunohistochemical staining of both osteoclastic and pleomorphic giant cells in this case indicates that these cells are histogenetically related.

Entities:  

Mesh:

Year:  1990        PMID: 2227926     DOI: 10.1016/0046-8177(90)90157-z

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

1.  Proliferation of osteoclast-like giant cells in a metastatic bone tumor from stomach cancer: report of a case and analysis of the autopsy findings.

Authors:  T Saeki; K Mandai; S Moriwaki; K Yamagami; N Sakamoto; W Takiyama; S Takashima
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Undifferentiated Carcinoma With Osteoclastic Giant Cells of the Pancreas: Clinicopathologic Analysis of 38 Cases Highlights a More Protracted Clinical Course Than Currently Appreciated.

Authors:  Takashi Muraki; Michelle D Reid; Olca Basturk; Kee-Taek Jang; Gabriela Bedolla; Pelin Bagci; Pardeep Mittal; Bahar Memis; Nora Katabi; Sudeshna Bandyopadhyay; Juan M Sarmiento; Alyssa Krasinskas; David S Klimstra; Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2016-09       Impact factor: 6.394

3.  Resectable pleomorphic giant cell carcinoma of the pancreas.

Authors:  T Yamamoto; K Hirohashi; H Tanaka; T Uenishi; T Shuto; S Kubo; H Kinoshita
Journal:  Int J Pancreatol       Date:  2001

4.  Osteoclastic and pleomorphic giant cell tumors of the pancreas: A review of clinical, endoscopic, and pathologic features.

Authors:  Jill C Moore; Joel S Bentz; Kristen Hilden; Douglas G Adler
Journal:  World J Gastrointest Endosc       Date:  2010-01-16

5.  In vitro induction of giant cell tumors from cultured hamster islets treated with N-Nitrosobis(2-Oxopropyl)amine.

Authors:  H Matsuzaki; B M Schmied; A Ulrich; S K Batra; P M Pour
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Giant cell tumor of the pancreas arising in the ovarian-like stroma of a mucinous cystadenocarcinoma.

Authors:  S Bergman; L J Medeiros; T Radr; D C Mangham; K B Lewandrowski
Journal:  Int J Pancreatol       Date:  1995-08

Review 7.  Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a rare case report and review of the literature.

Authors:  Shambhu K Sah; Ying Li; Yongmei Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  A case of osteoclast-like giant cell tumor of the pancreas with ductal adenocarcinoma: histopathological, immunohistochemical, ultrastructural and molecular biological studies.

Authors:  Young-Eun Joo; Tag Heo; Chang-Hwan Park; Wan-Sik Lee; Hyun-Soo Kim; Jung-Chul Kim; Yang-Seok Koh; Sung-Kyu Choi; Chol-Kyoon Cho; Jong-Sun Rew; Sei-Jong Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

9.  Mixed pleomorphic-osteoclast-like tumor of the pancreas. Light microscopical, immunohistochemical, and molecular biological studies.

Authors:  B Gatteschi; S Saccomanno; F G Bartoli; S Salvi; G Liu; V Pugliese
Journal:  Int J Pancreatol       Date:  1995-10

10.  An unusual epithelial pleomorphic giant cell tumour of the pancreas with osteoclast-type cells.

Authors:  A Martin; P Texier; J M Bahnini; J Diebold
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.